Skip to main content
Article
Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine
International Journal of Cancer (2005)
  • Hiroya Takeuchi, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA, USA
  • Donald L. Morton, John Wayne Cancer Clinic, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA, USA
  • David Elashoff, University of California, Los Angeles
  • Dave S.B. Hoon
Publication Date
December 20, 2005
DOI
10.1002/ijc.21267
Citation Information
Hiroya Takeuchi, Donald L. Morton, David Elashoff and Dave S.B. Hoon. "Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine" International Journal of Cancer Vol. 117 Iss. 6 (2005) p. 1032 - 1038
Available at: http://works.bepress.com/dave-hoon/255/